GDC-0570

N/A

Report date: 2026/04/23 20:00:25
NME

Base Information

Drug NameGDC-0570
Drug Alias NameGDC-0570NB004NB-004
ClassificationSmall molecules
Mechanisms of ActionSerine/threonine-protein kinase pim-3 inhibitorsProto-oncogene serine/threonine-protein kinase Pim-1 inhibitorsSerine/threonine-protein kinase pim-2 inhibitors
TargetsSerine/threonine-protein kinase pim-3Proto-oncogene serine/threonine-protein kinase Pim-1Serine/threonine-protein kinase pim-2
Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGenentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesGenentech IncNingbo Tai Kang Medical Technology Co LtdNingbo NewBay Medical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic NeoplasmsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A